#netter1 résultats de recherche
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism

PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost

Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana

Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO




Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…

#Novartis reports clinically relevant improvement in median overall survival data in final analysis of pivotal #NETTER1 study with targeted #RadioligandTherapy #Lutathera 1stoncology.com/blog/novartis-…
PRRT goes mainstream. exciting times ahead! #PRRT #NETcancer #NETTER1 abc6.com/story/30125072…
#Therametrics subsidiary has been selected to extend international #PhaseIII clinical trial #Netter1 ow.ly/CtP1Y
In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism

PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana

Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO




Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…

VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost

PRRT goes mainstream. exciting times ahead! #PRRT #NETcancer #NETTER1 abc6.com/story/30125072…
#Therametrics subsidiary has been selected to extend international #PhaseIII clinical trial #Netter1 ow.ly/CtP1Y
VIDEO: NETTER-1 Phase III Trial Results Meet Primary Endpoint oncologytube.com/video/netter-1… @MoffittNews #GI17 #netter1 @ASCOPost

Final Overall Survival In The Phase 3 NETTER-1 Study Jonathan Strosberg, MD @MoffittResearch @MoffittNews @NANETS1 #ASCO21 #NETTER1 #Melanoma #Cancer #Research oncologytube.com/video/39985/jo…

Datos finales de eficacia y seguridad del estudio #NETTER1 presentados en el congreso #WorldGI2021. ➕OS 36 vs 48 meses (p 0.3) ➕36% crossover ➕1.8% MDS ➕5.4% toxicidad renal @NievesM42607618 @DrMunozdeNova @endobioinfo @GreyVB @myESMO @_SEOM @Netespana

Long term OS and safety data from the NETTER1 trial: PRRT in midgut NET #WorldGI2021 ➡️ significant PFS but non-significant OS d/t crossover - not a surprise 🙄 ➡️ no new long term safety signals for MDS and renal toxicity ⏭ what is the value of PRRT re-treatment? @myESMO




In our discussion with @helops79 and @ProfKHerrmann, we touched on the role of PRRT in NETs. A few key studies to keep in mind (⬆️PFS): - #COMPETE - #COMPOSE - #NETTER1 - #NETTER2 #OncTwitter #MedTwitter #gism

PRRT - Radioligand Rx options in Neuroendocrine Tumors (NETs) with @helops79 & Ken Herrmann ✅ Different molecules ✅ Squencing ✅ Scans Full discussion: oncbrothers.com/net-prrt-2025 - m.youtube.com/watch?si=mYVB6… - Also on the “Oncology Brothers” podcast #OncTwitter #MedTwitter
Something went wrong.
Something went wrong.
United States Trends
- 1. phil 94.4K posts
- 2. phan 81.3K posts
- 3. Falcons 15.4K posts
- 4. Jorge Polanco 6,667 posts
- 5. Columbus 232K posts
- 6. #BillsMafia 5,717 posts
- 7. Mitch Garver N/A
- 8. Go Bills 7,881 posts
- 9. Bijan 3,575 posts
- 10. Doug Eddings 1,107 posts
- 11. Kincaid 1,777 posts
- 12. Joe Davis N/A
- 13. Middle East 329K posts
- 14. Jake Moody N/A
- 15. Monday Night Football 7,549 posts
- 16. Martin Sheen 1,934 posts
- 17. Springer 11.1K posts
- 18. Yesavage 3,502 posts
- 19. Pentagon 25.9K posts
- 20. Bears 36.2K posts